According to a new report published by
Allied Market Research, titled, "Antibacterial Coatings Market for
Medical Implants: Global Opportunity Analysis and Industry Forecast, 2017-2023," the
market was valued at $120.22 million in 2016, and is projected to reach $343.16
million by 2023, registering a CAGR of 16.1% from 2017 to 2023. Metallic
coatings segment held around three-fourths share of the total market in 2016.
Antibacterial coatings are materials that
prevent the bacterial adhesion and biofilm formation on the surface of medical
implants. In addition, they act as anti-thrombotic coating, which prevents the
formation of thrombus during bacterial infections after the surgery in patient.
So accordingly, medical implants are coated with antibacterial coating to
obtain an ideal potent surface that can provide protection against the
pathogens.
Click Here
To Access Free Sample Report: https://www.alliedmarketresearch.com/request-sample/4462
The major factors that drive the global
antibacterial coatings market for medical implants are increase in incidence of
implant-associated infections, demand for implantable devices, rise in bone
related and cardiovascular disorders, and growth of geriatric population.
However, high cost of antibacterial coatings, few drawbacks of silver coatings,
and time-consuming regulatory approvals are expected to restrain the market
growth. Conversely, growth in need of better healthcare services in the
emerging markets, such as China and India, and development of novel
antibacterial coatings are expected to provide lucrative opportunities to the
market players.
The metallic coatings segment occupied the
highest share in 2016, owing to the usage applicability and availability of
metallic coatings in medical & clinical settings. Furthermore, the metallic
coating segment is expected continue its dominance in the market during the
forecast period. The utilization rate of antibacterial coating for cardiac
implants is high, however orthopedic implants is expected to grow at a high
CAGR during the forecast period. This is attributed to increase in incidence of
bone related disorders such as fractures or replacement of joints leading rise
in use of orthopedic implants.
Key Findings of
the Antibacterial Coatings Market:
- Non-metallic coating segment is expected
to grow at a CAGR of 13.8% from 2017 to 2023.
- Metallic coatings segment accounted for
around three-fourths share of the global antibacterial coatings market for
medical implants in 2016.
- Cardiac implants segment accounted for
more than one-fifth share of the global antibacterial coatings market for
medical implants in 2016.
- Asia-Pacific is expected to grow at the
highest CAGR of 17.4%, from 2017 to 2023.
- North America accounted for around
one-third share of the global antibacterial coatings market for medical
implants in 2016.
For
Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/4462
North America was the leading revenue
contributor to the global antibacterial coatings market for medical implants.
This is attributed to the early adoption of technologically advanced coating
and high use of implantable devices due to rise in incidence of chronic
disorders. However, Asia-Pacific is expected to grow at the highest CAGR during
the study period, due to increase in affordability, surge in healthcare
expenditure, and growth in awareness about implantation surgeries.
The major companies profiled in the report
are aap Implantate AG, AST Products, Inc., BioCote Ltd, Covalon Technologies
Ltd., DOT GmbH, Harland Medical Systems Inc., Hydromer, Inc., Koninklijke DSM
N.V., Sciessent LLC, and Specialty Coating Systems, Inc.
No comments:
Post a Comment